The initiative is set to wind up at the end of this year, although some of its work will continue. With demand for COVID-19 vaccines dwindling, the partners are now working out how best to use the remaining cash – a significant sum in global health – alongside the donors who originally pledged it.
Ghana has become the first country in the world to approve a new malaria vaccine from Oxford University, a potential step forward in fighting a disease that kills hundreds of thousands of children each year.
Novavax Inc.’s shares plunged 28% in U.S. early trading on Wednesday, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business.
The head of the GAVI vaccine alliance suggested it was too early to end the COVID-19 emergency, saying that the pandemic “could get worse”.
The company cited Gavi’s failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility.
COVID disrupted measles vaccinations in Africa and now cases are surging By Edward Mcallister and Jennifer Rigby BUNDUNG, Gambia/LONDON, Oct 24 (Reuters) – Clutching an umbrella, medical records and her […]
Moderna Inc. (MRNA.O) has agreed to provide its new variant-adapted COVID-19 vaccine to the global scheme aiming to deliver shots to the world’s poorest people.
Global vaccine alliance GAVI has set up financial instruments that will allow the group to immediately access pledged donor funding if it needs to buy vaccines for future pandemics, Chief Executive Seth Berkley told Reuters.
Supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, officials close to the roll-out told Reuters, after disruptions at drugmaker GSK.